TESTOSTERONE CYP 100 MG/ML W/PRES — Class II drug recall D-1241-2016
Terminated recall by Medaus, Inc., reported 2016-07-20, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-1241-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Medaus, Inc., Birmingham, AL, United States |
| Recall initiated | 2016-05-13 |
| Classified | 2016-07-08 |
| Reported by FDA | 2016-07-20 |
| Terminated | 2017-06-16 |
| Distributed | Nationwide (US) |
| Countries outside the US | JP, NZ |
| Quantity | 500 ml |
| Reason classes | sterility |
| Lot numbers | 160115-17 |
| Expiration dates | 2016-07-13 |
Product
TESTOSTERONE CYP 100 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials, b) 2ML Vials, c) 3ML Vials, and d) 5 ML Vials, MEDAUS PHARMACY
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1241-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.